Do I have to lift weights while on a GLP-1?

Written and medically reviewed by Zahraa Sater, M.D., M.P.H.

Reviewed August 12, 2026 · Next review due August 12, 2027

Short answer

Resistance training is the strongest signal your body has to keep muscle while you are in an energy deficit. The 2025 joint advisory from four obesity and nutrition societies recommends strength training at least three times a week alongside at least 150 minutes of aerobic activity during GLP-1 therapy. Walking alone does not provide that signal.

Muscle is expensive tissue to maintain, and a body in an energy deficit will shed anything it is not being asked to use. Resistance training is the request. It is the reason two people can lose the same 20 kg and end up with visibly different bodies and different function.

What the current guidance says

The 2025 joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society recommends strength training at least three times a week, plus at least 150 minutes a week of aerobic activity, alongside a protein intake of 1.2 to 1.6 g/kg per day, for anyone losing weight on GLP-1 therapy. Those three elements work together. Protein without the training stimulus and training without the protein both underperform.

What actually counts as resistance training

It means loading a muscle against resistance until it is genuinely challenged, then progressively increasing that load. Free weights, machines, resistance bands and bodyweight work all qualify. Six to eight exercises covering legs, hips, back, chest, shoulders and trunk, two or three sets each, twice or three times a week, is a sufficient programme for most people. Walking is valuable for cardiovascular health, glucose control and mood, and it does not preserve muscle. Neither does yoga alone, in most formats.

How to start if you have never trained

Begin before you escalate to a higher dose, not after, because the first months carry the fastest weight loss. Start with movements you can perform with control: a sit to stand from a chair, a hip hinge, a row, a press, a carry. Two sessions of 25 minutes a week performed consistently for six months beats a five day plan that stops in week three. Expect strength to rise at first even while weight falls, because early gains are largely neurological. If you have joint disease, cardiac disease or are over 65, ask for a programme designed around those constraints rather than skipping the training.

Book the sessions into your week the way you book the injection. Track one lift and one function marker, such as how many chair stands you can do in 30 seconds, and recheck them every three months. If the scale is falling and those numbers are falling with it, the plan needs changing before you lose more weight.

The clinical detail

The 2025 joint advisory specifies resistance training three or more times weekly and at least 150 minutes of aerobic activity weekly during GLP-1 therapy, alongside 1.2 to 1.6 g/kg per day of protein, to attenuate loss of lean mass. In the STEP 1 body composition substudy lean body mass fell 9.7 percent while fat mass fell 19.3 percent, and the improvement in lean to fat ratio was greatest in those achieving 15 percent or more weight loss, which supports treating lean mass preservation as dose and rate dependent. Function is measurable in clinic without imaging: 30 second sit to stand repetitions, gait speed over 4 metres, and hand grip dynamometry all track meaningful change and can be repeated every three months.

Written and medically reviewed by Zahraa Sater, M.D., M.P.H.

Reviewed August 12, 2026 · Next review due August 12, 2027

Sources

  1. Nutritional Priorities to Support GLP-1 Therapy for Obesity: a joint Advisory. American Journal of Clinical Nutrition
  2. Muscle matters: the challenge of preserving lean mass during obesity treatment. Healio Endocrine Today
  3. Impact of Semaglutide on Body Composition in Adults With Overweight or Obesity: Exploratory Analysis of the STEP 1 Study. Journal of the Endocrine Society. doi:10.1210/jendso/bvab048.030

Was this answer helpful?

This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.